<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib73">
 <element-citation publication-type="journal" id="sref73">
  <person-group person-group-type="author">
   <name>
    <surname>Painter</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Robertson</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Trost</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Godkin</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lampert</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Painter</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <volume>56</volume>
  <year>2012</year>
  <fpage>2726</fpage>
  <lpage>2734</lpage>
  <pub-id pub-id-type="doi">10.1128/aac.05983-11</pub-id>
  <pub-id pub-id-type="pmid">22391537</pub-id>
 </element-citation>
</ref>
